{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:21:04Z","timestamp":1791534064968,"version":"4.3.4"},"reference-count":42,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:p>DCs (dendritic cells) are present in atherosclerotic lesions leading to vascular inflammation, and the number of vascular DCs increases during atherosclerosis. Previously, we have shown that the levels of circulating DCPs (DC precursors) are reduced in acute coronary syndromes through vascular recruitment. In the present study, we have investigated whether DCP levels are also reduced in stable CAD (coronary artery disease). The levels of circulating mDCPs (myeloid DCPs), pDCPs (plasmacytoid DCPs) and tDCP (total DCPs) were investigated using flow cytometry in 290 patients with suspected stable CAD. A coronary angiogram was used to evaluate a CAD score for each patient as follows: (i) CAD excluded (n=57); (ii) early CAD (n=63); (iii) moderate CAD (n=85); and (iv) advanced CAD (n=85). Compared with controls, patients with advanced stable CAD had lower HDL (high-density lipoprotein)-cholesterol (P=0.03) and higher creatinine (P=0.003). In advanced CAD, a significant decrease in circulating mDCPs, pDCPs and tDCPs was observed (each P&amp;lt;0.001). A significant inverse correlation was observed between the CAD score and mDCPs, pDCPs or tDCPs (each P&amp;lt;0.001). Patients who required percutaneous coronary intervention or coronary artery bypass grafting had less circulating mDCPs, pDCPs and tDCPs than controls (each P&amp;lt;0.001). Multiple stepwise logistic regression analysis suggested mDCPs, pDCPs and tDCPs as independent predictors of CAD. In conclusion, we have shown that patients with stable CAD have significantly lower levels of circulating DCPs than healthy individuals. Their decrease appears to be an independent predictor of the presence of, and subsequent therapeutic procedure in, stable CAD.<\/jats:p>","DOI":"10.1042\/cs20080392","type":"journal-article","created":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T16:41:39Z","timestamp":1222188099000},"page":"353-363","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease"],"prefix":"10.1042","volume":"116","author":[{"given":"Atilla","family":"Yilmaz","sequence":"first","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Schaller","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Cicha","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Altendorf","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stumpf","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Klinghammer","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner\u00a0G.","family":"Daniel","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph\u00a0D.","family":"Garlichs","sequence":"additional","affiliation":[{"name":"Medical Clinic II, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2009,1,15]]},"reference":[{"key":"2021120120550308600_B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2021120120550308600_B2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0008-6363(96)88642-1","article-title":"S-100 positive cells in human arterial intima and in atherosclerotic lesions","volume":"29","author":"Bobryshev","year":"1995","journal-title":"Cardiovasc. Res."},{"key":"2021120120550308600_B3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.ATV.21.4.503","article-title":"Network of vascular-associated dendritic cells in intima of healthy young individuals","volume":"21","author":"Millonig","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021120120550308600_B4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"2021120120550308600_B5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1440-1711.2002.01118.x","article-title":"Dendritic cells, chemokine receptors and autoimmune inflammatory diseases","volume":"80","author":"Cravens","year":"2002","journal-title":"Immunol. Cell Biol."},{"key":"2021120120550308600_B6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(01)00456-1","article-title":"Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity","volume":"106","author":"Liu","year":"2001","journal-title":"Cell"},{"key":"2021120120550308600_B7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2004.04.027","article-title":"Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques","volume":"176","author":"Yilmaz","year":"2004","journal-title":"Atherosclerosis"},{"key":"2021120120550308600_B8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00395-006-0636-x","article-title":"Functional profile of activated dendritic cells in unstable atherosclerotic plaque","volume":"102","author":"Erbel","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"2021120120550308600_B9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.humpath.2007.02.004","article-title":"The expression of vascular dendritic cells in human atherosclerotic carotid plaques","volume":"38","author":"Kawahara","year":"2007","journal-title":"Hum. Pathol."},{"key":"2021120120550308600_B10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0008-6363(97)00229-0","article-title":"Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions","volume":"37","author":"Bobryshev","year":"1998","journal-title":"Cardiovasc. Res."},{"key":"2021120120550308600_B11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0008-6363(02)00447-9","article-title":"Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment?","volume":"55","author":"Alderman","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"2021120120550308600_B12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.CIR.0000047279.42427.6D","article-title":"Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions","volume":"107","author":"Aicher","year":"2003","journal-title":"Circulation"},{"key":"2021120120550308600_B13","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1161\/01.ATV.0000181744.58265.63","article-title":"Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells","volume":"25","author":"Ge","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021120120550308600_B14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/CIRCRESAHA.107.161653","article-title":"Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation","volume":"102","author":"Han","year":"2008","journal-title":"Circ. Res."},{"key":"2021120120550308600_B15","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/CIRCULATIONAHA.106.642801","article-title":"Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-\u03b1","volume":"114","author":"Niessner","year":"2006","journal-title":"Circulation"},{"key":"2021120120550308600_B16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacc.2006.01.078","article-title":"Decrease in circulating myeloid dendritic cell precursors in coronary artery disease","volume":"48","author":"Yilmaz","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021120120550308600_B17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexmp.2006.10.008","article-title":"Accumulation of immune cells and high expression of chemokines\/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques","volume":"82","author":"Yilmaz","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"2021120120550308600_B18","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/01.ATV.0000036418.04998.D5","article-title":"Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases","volume":"22","author":"Weis","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021120120550308600_B19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2004.09.003","article-title":"Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization","volume":"21","author":"Angeli","year":"2004","journal-title":"Immunity"},{"key":"2021120120550308600_B20","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques","volume":"101","author":"Llodra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021120120550308600_B21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/ATVBAHA.107.141515","article-title":"Platelets recruit human dendritic cells via Mac-1\/JAM-C interaction and modulate dendritic cell function in vitro","volume":"27","author":"Langer","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021120120550308600_B22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00019501-200605000-00007","article-title":"Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease","volume":"17","author":"Van\u00a0Vre","year":"2006","journal-title":"Coron. Artery Dis."},{"key":"2021120120550308600_B23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MCA.0b013e3282eff1ad","article-title":"Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro","volume":"18","author":"Dopheide","year":"2007","journal-title":"Coron. Artery Dis."},{"key":"2021120120550308600_B24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","article-title":"A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association","volume":"51","author":"Austen","year":"1975","journal-title":"Circulation"},{"key":"2021120120550308600_B25","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4049\/jimmunol.163.3.1409","article-title":"A CD1a+\/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells","volume":"163","author":"Ito","year":"1999","journal-title":"J. Immunol."},{"key":"2021120120550308600_B26","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J. Immunol."},{"key":"2021120120550308600_B27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/eurheartj\/ehi282","article-title":"Dendritic cells in atherosclerosis: current status of the problem and clinical relevance","volume":"26","author":"Bobryshev","year":"2005","journal-title":"Eur. Heart J."},{"key":"2021120120550308600_B28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0198-8859(02)00755-3","article-title":"Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells","volume":"63","author":"Penna","year":"2002","journal-title":"Hum. Immunol."},{"key":"2021120120550308600_B29","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.171.10.5571","article-title":"A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity","volume":"171","author":"Pichyangkul","year":"2003","journal-title":"J. Immunol."},{"key":"2021120120550308600_B30","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.4049\/jimmunol.181.8.5691","article-title":"Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction","volume":"181","author":"Naito","year":"2008","journal-title":"J. Immunol."},{"key":"2021120120550308600_B31","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1161\/CIRCULATIONAHA.107.757443","article-title":"Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart","volume":"118","author":"Takahashi","year":"2008","journal-title":"Circulation"},{"key":"2021120120550308600_B32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cardiores.2003.09.001","article-title":"Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis","volume":"60","author":"Skowasch","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"2021120120550308600_B33","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.21.11.1819","article-title":"Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India","volume":"21","author":"Mohan","year":"1998","journal-title":"Diabetes Care"},{"key":"2021120120550308600_B34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2362.2006.01604.x","article-title":"Lipoprotein(a), type\u00a02 diabetes and vascular risk in coronary patients","volume":"36","author":"Saely","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"2021120120550308600_B35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ahj.2006.01.011","article-title":"Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death","volume":"152","author":"May","year":"2006","journal-title":"Am. Heart J."},{"key":"2021120120550308600_B36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cca.2006.09.009","article-title":"Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease","volume":"377","author":"Rasouli","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"2021120120550308600_B37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2362.2007.01842.x","article-title":"Leptin, leptin soluble receptor and coronary atherosclerosis","volume":"37","author":"Hoefle","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"2021120120550308600_B38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1253\/circj.71.1067","article-title":"Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type\u00a02 diabetic patients","volume":"71","author":"Pu","year":"2007","journal-title":"Circ. J."},{"key":"2021120120550308600_B39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2840-5-27","article-title":"Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type\u00a02 diabetes","volume":"5","author":"Pu","year":"2006","journal-title":"Cardiovasc. Diabetol."},{"key":"2021120120550308600_B40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.amjcard.2006.11.032","article-title":"Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome","volume":"99","author":"Sukhija","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"2021120120550308600_B41","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"2021120120550308600_B42","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017493.03108.1C","article-title":"Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death","volume":"105","author":"Albert","year":"2002","journal-title":"Circulation"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/116\/4\/353\/438929\/cs1160353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/116\/4\/353\/438929\/cs1160353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:55:47Z","timestamp":1684547747000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/116\/4\/353\/68617\/Predictive-value-of-the-decrease-in-circulating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,15]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20080392","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,15]]}}}